Marissa Brittenham Sells 3,156 Shares of Surgery Partners, Inc. (NASDAQ:SGRY) Stock

Surgery Partners, Inc. (NASDAQ:SGRY) insider Marissa Brittenham sold 3,156 shares of Surgery Partners stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $24.09, for a total value of $76,028.04. Following the completion of the sale, the insider now owns 63,408 shares of the company’s stock, valued at approximately $1,527,498.72. The trade was a 4.74 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Surgery Partners Trading Down 0.0 %

NASDAQ:SGRY opened at $23.60 on Friday. Surgery Partners, Inc. has a fifty-two week low of $19.50 and a fifty-two week high of $33.97. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. The stock has a market capitalization of $3.01 billion, a PE ratio of -49.17, a price-to-earnings-growth ratio of 19.21 and a beta of 2.73. The business’s 50-day simple moving average is $23.58 and its 200-day simple moving average is $26.08.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings data on Monday, March 3rd. The company reported $0.39 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.01. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The business had revenue of $864.40 million for the quarter, compared to analysts’ expectations of $828.09 million. Sell-side analysts expect that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

SGRY has been the subject of several analyst reports. JPMorgan Chase & Co. decreased their target price on Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a research report on Tuesday, December 3rd. Bank of America initiated coverage on Surgery Partners in a research report on Monday, December 16th. They set a “buy” rating and a $30.00 target price for the company. Macquarie decreased their target price on Surgery Partners from $34.00 to $33.00 and set an “outperform” rating for the company in a research report on Tuesday. Finally, Royal Bank of Canada decreased their target price on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a research report on Wednesday, November 20th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, Surgery Partners presently has an average rating of “Moderate Buy” and an average target price of $36.63.

Hedge Funds Weigh In On Surgery Partners

Several institutional investors have recently modified their holdings of SGRY. KBC Group NV lifted its stake in Surgery Partners by 31.8% in the 3rd quarter. KBC Group NV now owns 2,385 shares of the company’s stock valued at $77,000 after acquiring an additional 576 shares in the last quarter. State of Wyoming lifted its stake in Surgery Partners by 94.4% in the 4th quarter. State of Wyoming now owns 4,002 shares of the company’s stock valued at $85,000 after acquiring an additional 1,943 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. lifted its stake in Surgery Partners by 12.1% in the 4th quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company’s stock valued at $91,000 after acquiring an additional 465 shares in the last quarter. MeadowBrook Investment Advisors LLC lifted its stake in Surgery Partners by 16.6% in the 4th quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company’s stock valued at $218,000 after acquiring an additional 1,460 shares in the last quarter. Finally, Tower Research Capital LLC TRC lifted its stake in Surgery Partners by 279.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,762 shares of the company’s stock valued at $228,000 after acquiring an additional 7,925 shares in the last quarter.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.